About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.10 (-5.00%)
AGN ASX Argenica Therapeutics Ltd
Loading watchlist status…
Argenica Therapeutics Ltd share price
AGN price activity
Last Price
$0.100
Change (24hr)
-0.01 AUD (5.00%)
Volume
178.93K
Volume (4w avg)
-
Open
$0.10
Day Range
$0.10 - $0.10
Previous Close
$0.10
Last Trade
05 Nov, 3:47 am GMT+0
Delayed
05 Nov, 3:47 am GMT+0
AGN price performance
-17.39%
5D
-26.92%
1M
-67.80%
YTD
-64.81%
1Y
Delayed
05 Nov, 3:47 am GMT+0
AGN details
AGN Market Signals